Months of Work Hang in the Balance as Moderna’s COVID-19 Vaccine Awaits AdComm Vote

A critical vote is set to take place today amongst those on a U.S. Food and Drug Administration (FDA) advisory panel in regard to the COVID-19 vaccine from Moderna. The Vaccines and Related Biological Products Advisory Committee will be determining whether the product should be authorized for emergency use, according to CNBC.